ALLISON VANWAGENEN: Open Payments
NPI 1124706874 · BINGHAMTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,210 in 49 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $900 · 2025 $1,210
Food & beverage: $1,049Education: $162
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $391 |
| Janssen Biotech, Inc. | 12 | $267 |
| UCB, Inc. | 3 | $99 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $85 |
| Lilly USA, LLC | 4 | $84 |
| Incyte Corporation | 3 | $70 |
| GENZYME CORPORATION | 2 | $56 |
| Arcutis Biotherapeutics, Inc. | 2 | $33 |
| Galderma Laboratories, L.P. | 2 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
Products named: TREMFYA, RINVOQ, SKYRIZI, Bimzelx, TALTZ, DUPIXENT, OPZELURA, Zoryve.
Industry payments across NY — which companies pay providers there.
